Kymera Therapeutics Stock Widgets and Gadgets
| KYMR Stock | USD 40.61 0.32 0.79% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- KYMR Kymera Therapeutics
- Latest Kymera Therapeutics Moves 7.8 percent Higher Will This Strength Last
- KYMR 40.61 0.32
- Low 40.48
- High 41.89
- Alpha -0.15
- Beta 1.14
- Return On Equity -0.26
- Return On Asset -0.15
- Profit Margin (1.91) %
- Operating Margin (19.28) %
- Current Valuation 2.15 B
- Shares Outstanding 64.77 M
- Shares Owned By Insiders 1.30 %
- Shares Owned By Institutions 98.69 %
- Number Of Shares Shorted 8.77 M
- Price To Book 2.92 X
- Price To Sales 30.04 X
- Revenue 78.59 M
- Gross Profit (133.84 M)
- EBITDA (143.2 M)
- Net Income (146.96 M)
- Cash And Equivalents 392.31 M
- Cash Per Share 7.61 X
- Total Debt 84.67 M
- Debt To Equity 0.04 %
- Current Ratio 4.60 X
- Book Value Per Share 13.79 X
- Cash Flow From Operations (102.83 M)
- Short Ratio 18.36 X
- Earnings Per Share (2.36) X
- Price To Earnings To Growth 0.64 X
- Target Price 58.84
- Number Of Employees 184
- Beta 2.22
- Market Capitalization 2.63 B
- Total Asset 575.76 M
- Retained Earnings (530.75 M)
- Working Capital 319.63 M
- Net Asset 575.76 M
- Accumulation Distribution 0.0337
- Daily Balance Of Power 0.227
- Rate Of Daily Change 1.01
- Day Median Price 41.19
- Day Typical Price 40.99
- Market Facilitation Index 1.41
- Price Action Indicator (0.41)
- Period Momentum Indicator 0.32
Market Snapshot Widget Example
DAX Index Germany | 20,903 1.20 | |
Taiwan Weighted Taiwan | 23,148 0.53 | |
PSI 20 Stock Portugal | 6,564 1.07 | |
CROBEX Croatia | 3,367 0.18 | |
Budapest SE Hungary | 84,879 0.94 | |
IDX 30 Jakarta Indonesia | 428.62 0.65 | |
ISEQ 20 Price Ireland | 1,632 0.91 | |
NYSE Comp USA | 19,607 0.30 | |
Tel Aviv 35 Israel | 2,525 0.41 | |
Coreshares Index Tracker South Afric | 1,119 0.18 | |
IPC MEXICO Mexico | 49,931 0.02 | |
KL Technology Malaysia | 60.74 1.13 | |
IBEX 35 Index Spain | 11,916 0.64 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,780 1.47 | |
SPASX Dividend Opportunities Australia | 1,683 0.31 | |
HNX 30 Vietnam | 462.19 1.35 | |
Bucharest BET-NG Romania | 1,229 0.12 | |
AMS Small Cap Netherlands | 1,274 0.47 | |
Oslo Exchange Mutual Norway | 1,445 0.51 | |
BEL Small Belgium | 8,518 0.44 | |
Basic Materials Brazil | 5,417 2.39 | |
Swiss Leader Price Switzerland | 1,986 0.0005 | |
Fondo Mutuo ETF Chile | 1,450 0.63 | |
Athens General Comp Greece | 1,525 1.18 | |
Stock Exchange Of Thailand | 1,341 0.88 | |
PX Prague Stock Czech Repub | 1,812 1.47 | |
THE PHILIPPINE STOCK Philippines | 6,352 1.38 | |
WIG 30 Poland | 2,948 1.30 | |
BIST Electricity Turkey | 518.27 0.19 |
Investing Ideas
In addition to having Kymera Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Kymera Therapeutics
Compare Kymera Therapeutics To Peers
Additional Tools for Kymera Stock Analysis
When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.